News|Articles|August 26, 2021

In the Lab eNewsletter

  • Pharmaceutical Technology's In the Lab eNewsletter, September 2021
  • Volume 16
  • Issue 09

Promega to Showcase Applications of Bioluminescent Research Tools at Global Seminar Series

Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.

Promega Corporation announced that it will showcase various applications of bioluminescence research tools at their Discover Glo 2021 conference, a virtual event which will be held Sept. 13–16, 2021.

The aim of the conference is to advance understanding in key therapeutic areas, such as targeted protein degradation and kinase biology. Each day will feature discussions focusing on a topic surrounding luciferase technologies.

These daily topics include:

  • Bioluminescence: Past, Present, Future (Sept. 13)
  • Applications of CRISPR Knock-in Tagging for Studying Endogenous Protein Dynamics (Sept. 14)
  • Understanding Kinase Target Engagement in Live Cells (Sept. 15)
  • Advances in Targeted Protein Degradation (Sept. 16)

Prominent speakers from various related fields will be in attendance. For a full list of these individuals, the company press release can be found here.

Source: Promega


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.